Positioned to gain market share as competitors like Rite Aid and Walgreens scale back.

Recommended as a buy on pullbacks, particularly through the CNBC Investing Club .

Highlighted as a value play shifting into high-growth specialty services.

Despite tech volatility, Cramer maintains that the "Mag 7" remain the core of a strong portfolio because they are run by "people who are too smart to bet against".

As of late April 2026, Jim Cramer’s strategy focuses on balancing "hot" tech holdings with "cold," undervalued sectors like healthcare to protect against a potential market pullback. He has specifically warned that the recent surge in AI-infrastructure and chip stocks is becoming "worrisome" as expectations may be outrunning fundamentals. ❄️ The "Cold" Opportunity: Healthcare